Navigation Links
Crucial Gene may Be Indicator of Breast Cancer Metastasis

Researchers at Fox Chase Cancer Center have zeroed in on a crucial gene, thought to be the reason for the spread of breast cancer and resistance// to long-term estrogen deprivation. The gene may be beneficial in ascertaining the risk factors of breast cancer reappearance, and would enable a good idea to specialists about potential treatment options.

The research targeted breast cancer cells which had developed resistance to a particular class of anti-hormone drug called aromatase inhibitors. These inhibitors cause the closure of an enzyme aromatase, which causes the body to produce estrogen outside the ovaries. These drugs offer the most effective hormone therapies for women whose estrogen in the body propels the growth of cancer cells.

Fox Chase Cancer Center biochemist Joan S. Lewis-Wambi, Ph.D said, "Unfortunately, one of the drawbacks to extended use of an AI may be that some of the cancer cells develop resistance to the drug and are able to grow and spread independent of estrogen. Our laboratory has developed several AI-resistant breast cancer cell lines and have found that these cells are very invasive compared to AI-sensitive breast cancer cells. Analyses of gene activity in these AI-resistant cells have shown that they express high levels of genes associated with invasiveness and metastasis."

The researchers also found a solution, to employ molecules called "small interfering RNAs" which would quash the gene called CEACAM6 (carcinoembryonic antigen-related cell adhesion molecule6). Lewis-Wambi concluded, “Overall, these findings identify CEACAM6 as a unique mediator of the aggressiveness and spread of AI-resistant breast cancer. This suggests that it might be an important biomarker for metastasis and a possible target for novel treatments for patients with metastatic breast cancer.”
SAV/
'"/>




Page: 1

Related medicine news :

1. Fear Factor Found To Be Crucial In Shaping An Individual’s Personalit
2. Prevention And Control Of Diabetes Crucial To Indian Population
3. Media Plays Crucial Role In Flu Vaccinations
4. Farming Plays A Crucial Role In Reducing Global Warming
5. Crucial steps taken by the Chinese government to protect its grasslands
6. Eye Hygiene Crucial To Keep Fungus at Bay
7. Crucial to regulate your body pH, key determiner for good health
8. Heart Has Enough Oxygen to Survive Hypothermia; CPR Crucial
9. Timely Detection of Type-1 Diabetes Crucial
10. Scientist Discovers Crucial Part of Blood-Clotting Process
11. Genetics Plays A Crucial Role In Preemies Destructive Eye Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... Huntington Beach, CA (PRWEB) , ... January 19, ... ... for Oral Health, is now offering treatments for patients with sleep apnea and ... far-reaching consequences for dental and physical health. Dr. Rassouli provides personalized care to ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... protection and financial planning services to communities throughout eastern Georgia, is embarking on ... heart disease. , Heart disease kills more Americans every year than anything else, ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative messages to prevent ... contest from Impact Teen Drivers and California Casualty. Entries from students aged 14-22 ... grants totaling $15,000 will be awarded for the best peer-to-peer messages sharing solutions ...
(Date:1/19/2017)... ... 19, 2017 , ... The 21st Century Cures Act’s Impact on Medical Devices:, ... 2016 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          , ... to thrive this year? , The passage of the act means devicemakers will be ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... American Osteopathic College of Proctology) announced today the opening of 3 medical ... ( http://www.hemorrhoidsremovalcenterscalifornia.com ): Hemorrhoids Center of Los Angeles (Beverly Hills), Hemorrhoids Center ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... blood analysis instruments and consumables for the medical and ... discuss its financial results for the third quarter fiscal ... be at 4:15 p.m. ET on Thursday, January 26, ... third quarter fiscal year 2017 after the market closes ...
(Date:1/19/2017)... 2017 Shire plc (LSE: SHP, ... Food and Drug Administration (FDA) has acknowledged receipt of ... (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine salts ... treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected ... 2017, the designated Prescription Drug User Fee Act (PDUFA) ...
(Date:1/19/2017)... January 19, 2017 While ... serious about reducing the FDA,s regulatory strictness as ... the medical drug industry, many of the leading ... clinical trials and development of advanced drug treatments ... with recent developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: